168 related articles for article (PubMed ID: 30857958)
1. Precision oncology giveth and precision oncology taketh away.
Saltz LB
Lancet Oncol; 2019 Apr; 20(4):464-466. PubMed ID: 30857958
[No Abstract] [Full Text] [Related]
2. Making precision oncology the standard of care.
The Lancet Oncology
Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559
[No Abstract] [Full Text] [Related]
3. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
4. [The use of targeted therapies in oncology and their impact in the design of clinical trials: epidermal growth factor receptors 1 and 2 as a paradigm].
Dalmases A; Rojo F; Rovira A; Albanell J
Med Clin (Barc); 2013 Aug; 141(4):176-80. PubMed ID: 23809407
[No Abstract] [Full Text] [Related]
5. The quest for efficient trial designs in precision oncology.
Schuler M
Lancet Oncol; 2020 Dec; 21(12):1539-1541. PubMed ID: 33125908
[No Abstract] [Full Text] [Related]
6. Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.
Burstein HJ
Expert Rev Anticancer Ther; 2005 Aug; 5(4):581-3. PubMed ID: 16111459
[No Abstract] [Full Text] [Related]
7. [Antibody-drug conjugate--a new age for personalized cancer treatment].
Bertholjotti I
Chimia (Aarau); 2011; 65(9):746-8. PubMed ID: 22026193
[No Abstract] [Full Text] [Related]
8. [Cancerology: search for better therapeutic schemes].
Mabro M
Presse Med; 1998 Jul 4-11; 27(24):1228-30. PubMed ID: 9767784
[No Abstract] [Full Text] [Related]
9. Oncologist encouraged by cancer advance. Dr. Blachly steps up the case for breast cancer screening.
Marshall E
J Ark Med Soc; 1999 Oct; 96(5):174-5. PubMed ID: 10544548
[No Abstract] [Full Text] [Related]
10. The board giveth and taketh away.
Rozovsky LE; Rozovsky FA
Can Doct; 1987 Oct; 53(10):GP6-7. PubMed ID: 10285964
[No Abstract] [Full Text] [Related]
11. BLOOD--"TAKETH AWAY, OR GIVETH".
GOLDOWSKY SJ
R I Med J; 1964 Oct; 47():496-7. PubMed ID: 14199674
[No Abstract] [Full Text] [Related]
12. [Precision medicine in oncology: Challenges, stakes and new paradigms].
Cox S; Rousseau-Tsangaris M; Abou-Zeid N; Dalle S; Leurent P; Cutivet A; Le HH; Kotb S; Bogaert B; Gardette R; Baran Y; Holder JM; Lerner L; Blay JY; Cambrosio A; Tredan O; Denèfle P
Bull Cancer; 2019 Feb; 106(2):97-104. PubMed ID: 30713005
[No Abstract] [Full Text] [Related]
13. New studies contribute to ongoing quest for better breast cancer screening, care.
Hampton T
JAMA; 2008 Oct; 300(15):1749-50. PubMed ID: 18854526
[No Abstract] [Full Text] [Related]
14. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
15. Improving breast cancer care.
Munster PN
Cancer Control; 2002; 9(6):455-6. PubMed ID: 12514562
[No Abstract] [Full Text] [Related]
16. [Orientation of medical oncology treatment in precision medicine era].
Shi Y; Sun Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(31):2518-21. PubMed ID: 26711383
[No Abstract] [Full Text] [Related]
17. Precision Oncology: 2022 in Review.
Rosen E; Drilon A; Chakravarty D
Cancer Discov; 2022 Dec; 12(12):2747-2753. PubMed ID: 36458431
[TBL] [Abstract][Full Text] [Related]
18. Congress and science. First spending bill giveth--and taketh away.
Mervis J
Science; 2011 Nov; 334(6059):1041. PubMed ID: 22116847
[No Abstract] [Full Text] [Related]
19. Dendritic cells giveth and taketh away.
Abbas AK; Sharpe AH
Nat Immunol; 2005 Mar; 6(3):227-8. PubMed ID: 15716967
[No Abstract] [Full Text] [Related]
20. What one lipid giveth, another taketh away.
Joyce S; Spiller BW; Van Kaer L
Nat Immunol; 2019 Dec; 20(12):1559-1561. PubMed ID: 31636467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
